Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Ferracin

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Haematologica|October 4, 2024
Epigenetic age acceleration in hematopoietic stem cell transplantationMargherita Ursi, Katarzyna Malgorzata Kwiatkowska, Chiara Pirazzini, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Modulation of mismatch repair and genomic stability by miR-155Nicola Valeri, Pierluigi Gasparini, Muller Fabbri, et al.
The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical featuresFortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Cells|September 13, 2025
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery-Dreifuss Muscular Dystrophy FibroblastsEleonora Cattin, Elisa Schena, Elisabetta Mattioli, et al.
Cancer Cell|September 6, 2007
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomasGeorge A Calin, Chang-gong Liu, Manuela Ferracin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Mechanisms of Ageing and Development|February 5, 2022
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortalityAngelica Giuliani, Giulia Matacchione, Deborah Ramini, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
The New England Journal of Medicine|April 22, 2005
Familial cancer associated with a polymorphism in ARLTS1George Adrian Calin, Francesco Trapasso, Masayoshi Shimizu, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Haematologica|October 4, 2024
Epigenetic age acceleration in hematopoietic stem cell transplantationMargherita Ursi, Katarzyna Malgorzata Kwiatkowska, Chiara Pirazzini, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Modulation of mismatch repair and genomic stability by miR-155Nicola Valeri, Pierluigi Gasparini, Muller Fabbri, et al.
The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical featuresFortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Cells|September 13, 2025
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery-Dreifuss Muscular Dystrophy FibroblastsEleonora Cattin, Elisa Schena, Elisabetta Mattioli, et al.
Cancer Cell|September 6, 2007
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomasGeorge A Calin, Chang-gong Liu, Manuela Ferracin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Mechanisms of Ageing and Development|February 5, 2022
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortalityAngelica Giuliani, Giulia Matacchione, Deborah Ramini, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
The New England Journal of Medicine|April 22, 2005
Familial cancer associated with a polymorphism in ARLTS1George Adrian Calin, Francesco Trapasso, Masayoshi Shimizu, et al.
Pageof 19